Switch to:
GuruFocus articles
Headlines from internet
Nov-23-17$105.16 (+0%)
08:33AMDaily Pharma Scoop Exelixis Still Attractive Portolas Bevyxxa Pluristem Patent Seekingalpha
08:00AMGOP Tax Fix Could Zero Out Orphan Drug Tax Credit theStreet
Nov-22-17$105.16 (+0.63%)
02:14PMSorry Indexing Problem Seekingalpha
09:29AMJ&J Seeks Darzalex's Label Expansion in First-Line Setting Zacks
09:19AMNext Billion Dollar Blockbuster Value Investors Look Omeros Corporation Part 1 Seekingalpha
08:39AMMystery Stocks Revealed 88 Stock Portfolio Along 2018 Income Estimates Seekingalpha
06:35AMBiotech Stock Roundup: RARE drug Gets FDA Nod, Acorda, Cytokinetics Hit by Pipeline Setbacks Zacks
Nov-21-17$104.5 (+1.31%)
11:07AMJuno Clinical Trial Updates Continue Impress Seekingalpha
Nov-20-17$103.15 (-0.91%)
02:42PMAgios Posts New Data on Glioma Candidate from Dose Expansion Zacks
12:39PMSix promising stocks to buy when the biotech correction ends MarketWatch
Nov-19-17
09:21PMVictory Formation Long Short Portfolio Update November 2017 Seekingalpha
Nov-17-17$104.1 (+0.73%)
01:43PMDenali Therapeutics Files Raise 100 Million Ipo Seekingalpha
08:53AMCancer Space Update: Label Expansion for Three Major Drugs Zacks
08:30AMCan This Tiny Biotech Stock Pay Off Big for Celgene? Fool
07:44AMCelgene CAR-T Therapy Gets Breakthrough Therapy Designation Zacks
06:09AMBiotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3 Zacks
Nov-16-17$103.35 (+3%)
08:00AMWatch Gilead Junos Strategy Might Just Pay Seekingalpha
Nov-15-17$100.34 (+1.5%)
08:17PM3 Indisputable Reasons Why AbbVie Is the Best Big Pharma Stock Fool
04:46PMDaily Pharma Scoop Portola Ahead Catalysts Astrazeneca Gets Two Fda Approvals Gw Seekingalpha
Nov-13-17$101.16 (-1.15%)
10:16AMA Rare Quarterly Appearance by bluebird bio Inc.'s Management Fool
09:31AM3 Top Healthcare Stocks to Buy in November Fool
Nov-12-17
10:43AMValeant Surges Post Q3 Reassessment Seekingalpha
09:09AM5 Irresistible Reasons to Buy Celgene Stock Right Now (Hint: 1 Is that It's Dirt Cheap) Fool
08:00AM3 Top Biotech Stocks for 2018 Fool
Nov-10-17$102.34 (-0.12%)
03:02PMWhy Immunomedics, Inc. Jumped Higher Today Fool
12:02PMStocks Dog House Celgene Seekingalpha
06:52AMSell Pandora Cramers Lightning Round 11 9 17 Seekingalpha
Nov-09-17$102.46 (+0.8%)
10:21PMCVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round theStreet
07:34AM5 Top Stocks for November Fool
Nov-08-17$101.65 (-0.66%)
02:44PMDue Strong Growth Potential Celgene Undervalued Right Now Seekingalpha
01:31PMHow to Invest in Biotech Stocks Fool
11:57AMA Bright Spot in Blemished Biotech Barron's
Nov-07-17$102.33 (+0.68%)
07:00PMWhy Inovio Pharmaceuticals Stock Sank in October Fool
10:54AMStumbling Blocks Celgene Dependent Acceleron Hedge Bets Seekingalpha
06:02AMThe Only 3 Big Pharma Companies Growing Market Share Fool
05:56AMThe Zacks Analyst Blog Highlights: Facebook, Celgene, BlackRock, Danaher and BP Zacks
05:29AMValuation Dashboard Healthcare Update Seekingalpha
Nov-06-17$101.64 (+1.6%)
03:37PMTop Stock Reports for Facebook, Celgene & BlackRock Zacks
01:29PMTesla Shorts Have Made a Killing in the Last Month theStreet
11:41AMDaily Pharma Scoop Progenics Looks Promising Big Week Dynavax Keryx Ahead Catalyst Seekingalpha
Nov-04-17
03:02PM3 Biotech Stocks That Soared This Week: Are They Buys? Fool
Nov-03-17$100.04 (+1.87%)
05:18PMWhy Celgene Crashed 30% in October -- and What Now? Fool
01:14PMCorcept (CORT) Q3 Earnings Miss Estimates, Guidance Raised Zacks
12:47PMAllergan's 10 Important Lessons for Investors theStreet
08:34AM3 Reasons It's Smart to Buy Celgene's Stock Now Fool
Nov-02-17$98.2 (-2.32%)
04:13PMBuy Bad News in Celgene, General Electric, Under Armour theStreet
11:08AMAgios (AGIO) Q3 Loss Narrower than Expected, Revenues Up Y/Y Zacks
10:41AMTeva Stock Plunges on Earnings Results, but It's Still Not a Buy theStreet
10:30AM3 Stocks All Investors Need to Consider Fool
09:03AMJuno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis Fool
02:48AM89 Stock Portfolio Yield Risk Evaluation Playing Fire Seekingalpha
Nov-01-17$100.53 (-0.44%)
06:38PMThe 3 Stocks on the Motley Fool Money Team's Radar This Week Fool
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
02:10PMWhy bluebird bio Inc. Jumped Higher Today Fool
11:06AM3 Worst Performing Stocks in October Fool
09:37AMDaily Pharma Scoop Gilead Nash Geron Gets Boost Astrazenecas Oncology Portfolio Seekingalpha
09:17AMCelgenes Gilead Moment Seekingalpha
08:24AMBiotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts Zacks
07:18AMBuying Merck 52 Week Lows Seekingalpha
03:01AMLean Long Term Growth Portfolio October 2017 Update Seekingalpha
Oct-31-17$100.97 (+0%)
02:29PMIonis Down Big on Analyst Miss Fool
01:21PMCelgene Q3 2017 Far Zero Pipeline Value Seekingalpha
09:50AMBiotech Forum Daily Digest Possible Buyout Scenarios Neos Therapeutics Seekingalpha
08:30AMDaily Pharma Scoop Portolas Pdufa Pdli Makes Money Gwph Completes Rolling Nda Seekingalpha
07:34AMIf Celgene Buys This Biotech, Investors Should Win Big-Time Fool
03:00AMBiotech Analysis Central Daily Pharma News October 30 2017 Seekingalpha
Oct-30-17$100.97 (+2.85%)
04:19PMCelgene Corporation Has "Optionality and Opportunity" Fool
01:30PMCelgene Celg Presents Ectrims 2017 Ir Event Slideshow Seekingalpha
01:09PMNew Highs Listen Doom Mongers Seekingalpha
12:21PMBiotech Forum M Will Pick 2018 Seekingalpha
12:04PMDaily Pharma Scoop Gileads Unappreciated Opportunity Mercks Keytruda Stumble Epizymes Seekingalpha
10:27AM2 Top Pharma Stocks on Sale This Week Fool
09:41AMWhat's in the Cards for PFE, INCY and ACOR in Q3 Earnings? Zacks
01:00AMCelgene Disappoints; How to Praise, How to Blame: Doug Kass' Views theStreet
01:00AMWhere Have All the Buyers Gone?; Safety Dance -- Jim Cramer's Top Thoughts theStreet
Oct-29-17
08:15AMA Me-Too Push By Biopharma Is Crowding the Psoriasis Market Fool
03:00AMCelgene Got Pummeled Seekingalpha
Oct-28-17
08:15AMBig Opportunities to Buy Stocks Have Secretly Emerged theStreet
Oct-27-17$98.17 (-1.82%)
05:04PMCelgene At $100: Buy, Sell, or Hold? Fool
02:53PMCelgene Growth Reasonable Price Even Revised Guidance Seekingalpha
12:08PMAgios Pharmaceuticals (AGIO) Q3 Earnings: What's in Store? Zacks
09:13AMStock Market News For Oct 27, 2017 Zacks
07:50AMBetween Bad Mattel and Ugly Celgene, I Know Which One I Prefer: Market Recon theStreet
07:41AMDefinition Safety Stocks Changing Cramers Mad Money 10 26 17 Seekingalpha
06:03AMStop Panicking About Celgene Fool
06:00AMRoty Volume 1 Edition 43 Thoughts Biotech Sector Conserving Cash New Trades Seekingalpha
Oct-26-17$99.99 (-16.37%)
07:30PMWas Celgene’s Third Quarter Really Crash-Worthy? Fool
07:11PMRethinking Risk and Reward: Cramer's 'Mad Money' Recap theStreet
04:59PMWhat Happened in the Stock Market Today Fool
04:54PMThe Biggest Loser: Celgene Selloff is Worst in Years   Barron's
04:27PMRecently Merged DowDuPont Powers Dow Higher theStreet
04:13PMCelgene Crashes Reassessment Seekingalpha
04:04PMTwitter Surge and Nike Gains Lead Dow and S&P 500 Into Green theStreet
03:55PMCelgene: Short Sellers Stand Tall Barron's
03:47PMCelgene Sell Overdone Seekingalpha
02:33PMCelgene's Steep Decline Welcomed News for Short Sellers theStreet
02:11PMEarningsWatch: Celgene tanks and Twitter spikes ahead of Amazon, Alphabet reports MarketWatch
02:06PMVideo: Jim Cramer on Twitter, Comcast, Ford, Southwest Air, NXP and Celgene theStreet
01:27PMWhy Celgene Corporation Tumbled Today Fool
12:36PMHealthcare Earnings Roundup: Alexion, Bristol-Myers, Celgene theStreet
11:44AMDow Leads Market on Healthy Gains From Nike, DowDuPont theStreet
11:25AMVideo: Jim Cramer: I Don't Want to Panic and Sell Celgene theStreet
11:19AMCelgene's Stock Is Getting Absolutely Torched -- Don't Panic, Yet theStreet
10:30AMBristol-Myers: More Bad Medicine for the Market Barron's
10:29AMCelgene stock drops 19% on top drug’s sluggish sales, cuts to long-term guidance MarketWatch
10:24AMBiotech ETFs tumble as Celgene’s quarterly results and outlook weigh MarketWatch
10:02AMBusiest Day Of The Q3 Earnings Season Zacks
09:53AMBiotech ETFs tumble, with Celgene's stock headlining weakness MarketWatch
09:49AMCelgene (CELG) Tops Q3 Earnings, Sales Miss, Updates View Zacks
09:43AMCelgene Corporation 2017 Q3 Results Earnings Call Slides Seekingalpha
09:41AMMorning Movers: Celgene Slumps, American Airlines Flies, Twitter Soars Barron's
09:33AMS&P 500, Dow attempt rebound after biggest drop in 7 weeks MarketWatch
09:31AMTall Data in Short Time Zacks
09:00AMMorgan Stanley Just Found 37 Challenged Stocks That Still Have No Hope theStreet
08:32AMUPDATE: Celgene shares drop 15% on updated 2017 guidance MarketWatch
07:42AMStock Futures Rise After Positive Twitter, Ford Earnings theStreet
07:03AMCelgene (CELG) Beats on Q3 Earnings, Misses Sales Zacks
06:03AMAlphabet, Amazon and Microsoft - 5 Things You Must Know Before the Market Opens Thursday theStreet
Oct-25-17$119.56 (-0.65%)
08:45PMPrice Hikes Insulate Celgene From a Failure Fool
02:57PMExpect Gilead Seekingalpha
08:49AMDrug Stock Q3 Earnings Roster for Oct 26: GILD, BMY & More Zacks
08:23AMCelgenes Gedminus 0301 Failure Offers Peek Value Synergys Dolcanatide Seekingalpha
08:01AMWhat's Biogen's Big Risk? Fool
07:07AMBiotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod Zacks
Oct-24-17$120.34 (-1.66%)
08:16AM3 Top Biotech Stocks to Buy Now Fool
Oct-23-17$122.37 (+0.86%)
05:16PMIs Celgene (CELG) Poised for a Beat This Earnings Season? Zacks
05:14PMMongersen Fails Seekingalpha
02:39PMCelgene Still Great Pipeline Despite Setback Seekingalpha
02:02PMOzanimod Even Important Celgene Now Can Deliver Ms Seekingalpha
01:15PMTop Celgene cancer drugs now 20% more expensive after latest price hikes MarketWatch
12:35PMBiotech Forum Daily Digest Behind Uniqures Massive Rally Seekingalpha
12:32PMDaily Pharma Scoop Adamis Upside Potential J And Js Simponi Label Expansion Sgens Adcetris Seekingalpha
12:06PMWhy Agenus Inc. Stock Briefly Popped Today Fool
10:04AMBig Biotech Crispr Game Novartis Vertex Lead Pack Seekingalpha
09:30AMIs a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings? Zacks
08:23AMGilead Drug Approval Fuels Interest in CAR-T Space: 3 Stocks to Consider Zacks
08:19AM3 Gene Therapy Stocks That Could Make You Rich Fool
05:00AMStocks of Drug Upstarts Churn Amid Wider Market’s Steady Climb Bloomberg
03:14AMCelgene Dumps Chrons Disease Fight Yet Seekingalpha
Oct-22-17
06:26PMFutures and Dollar Rise as Trump Narrows Down Pool for Next Fed Chair theStreet
12:15PM3 Healthcare Stocks for Your Radar Fool
10:00AMThird-Quarter U.S. Economic Growth to Reveal Hurricane Damage in Week Ahead theStreet
08:17AMShould You Avoid Celgene Stock After Its Big Pipeline Setback? Fool
Oct-21-17
09:00AM3 Things October 21 2017 Celgenes New Gamble Pluristem Marches Ars Janssen Advances Seekingalpha
Oct-20-17$121.33 (-10.76%)
05:06PMWhat Happened in the Stock Market Today Fool
04:47PMThe Biggest Loser: Does Celgene Need to Pipe Up? Barron's
04:45PMGilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval Zacks
04:43PMCelgene Down on Discontinued Crohn's Disease Drug Study Zacks
04:15PMTax Cut Progress Gives Wall Street Enough Fuel to End With More Records theStreet
03:57PMAnother Regeneron Bear Is Born Barron's
03:01PMHow Big of a Deal Is Celgene's Flop? Fool
01:11PMWhy Celgene Corporation Dropped Today Fool
11:31AMCelgene dives 10% after ditching key drug MarketWatch
11:28AMTax Progress Boosts Wall Street, Major Indexes Trade Above Records theStreet
11:23AMCelgene: No Surprise? It's 10% Drop Says Otherwise Barron's
10:55AMCelgene: No Surprise? It’s 10% Drop Says Different. Barron's
09:50AMWhat's in the Cards for Amgen (AMGN) this Earnings Season? Zacks
09:49AMIs a Beat in the Cards for Vertex (VRTX) in Q3 Earnings? Zacks
09:36AMTax Reform Progress Pulls Stocks to Records Even as GE Sinks theStreet
09:00AM3 Things October 20 2017 Gileads Big Day Celgenes Bad News Crohns Bristol Myers Stretches Seekingalpha
07:52AMStocks Set to Open With More Records as Trump Tax Reform Makes Progress theStreet
07:31AMCelgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences Fool
07:29AMCelgene downgraded to neutral at Baird for 'increasing risks to long-term goals' MarketWatch
06:55AMWall Street Breakfast Tax Reform Steps Move Dollar Treasuries Seekingalpha
06:04AMTax Reform, GE and PayPal - 5 Things You Must Know Before the Market Opens Friday theStreet
Oct-19-17$135.96 (-0.88%)
05:27PMCelgene won't initiate phase 3 trial for Crohn's disease drug cnbc
05:13PMCelgene shares drop after Crohn's disease drug trials halted MarketWatch
03:09PMYes Car T Therapy May Mean Gilead Seekingalpha
10:01AMBiotech Developer Stocks Best Wealth Builders Now Seekingalpha
08:08AMThe Zacks Analyst Blog Highlights: IBM, Celgene, Procter & Gamble, Valero and Sprint Zacks
12:18AMJ And J Unattractive Seekingalpha
Oct-18-17$137.17 (-1.22%)
02:13PMTop Stock Reports for IBM, Celgene and Procter & Gamble Zacks
12:48PMDaily Pharma Scoop Azns Imfinzi Sbla Ablynx U S Ipo Teva Buy Seekingalpha
08:55AMZacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals Zacks
Oct-17-17$138.86 (+1.57%)
11:03PMValue System Amgen Looks Undervalued Seekingalpha
04:13PMUnitedHealth and a Bipartisan Healthcare Deal Sends Dow, S&P 500 to Records theStreet
02:55PMInnovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks Zacks
11:28AMDaily Pharma Scoop Everybodys Gilead Problem Halozymes Progress Ziopharms Gene Therapy Seekingalpha
11:07AMUnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains theStreet
09:04AMImmune Design's Sarcoma Candidate to Enter Phase III in 2018 Zacks
07:57AMThe Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene Zacks
Oct-16-17$136.71 (+0.18%)
05:07PMGlaxo's Shingles Vaccine Shingrix Gets Approval in Canada Zacks
04:43PMBayer to Sell Select Business Lines to Close Monsanto Buyout Zacks
11:18AMJohnson & Johnson earnings: All eyes on hurricane impact MarketWatch
08:38AMJ&J's Psoriasis Drug Stelara Gets FDA Nod for Adolescent Use Zacks
Oct-13-17$136.46 (-1.47%)
02:01PMValeant Reports Positive Results on Psoriasis Drug Siliq Zacks
Oct-12-17$138.5 (-0.76%)
05:59PMAccelerons Unique Pipeline Looks Undervalued Seekingalpha
05:56PMHere's Why Intercept (ICPT) Stock Lost 37% So Far in 2017 Zacks
10:51AMNIH partners 11 drugmakers to accelerate cancer therapy research cnbc
06:04AM7 Essential Rules for Investing in Biotech Stocks Fool
Oct-11-17$139.56 (-0.09%)
03:41PMAbbVie: You’re Upgrading It…Now? Barron's
01:33PMAnaptysbio Atopic Dermatitis Data Impresses Buy Secondary Seekingalpha
Oct-10-17$139.69 (+0.3%)
01:40PMA Short-Term Stock Pullback Is Coming - Here's How to Play Your Cards Right theStreet
12:36PM2 Cardinal Rules Successful Biotech Investing Seekingalpha
07:37AMBetter Buy: Biogen Inc. vs. Celgene Fool
06:04AM3 Stocks at 52-Week Highs Still Worth Buying Fool
06:02AM$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much Fool
Oct-09-17$139.27 (+0.04%)
09:00AMPfizer Growth Trajectory Locked Ready Launch Seekingalpha
07:38AMGame Plan Week Cramers Mad Money 10 6 17 Seekingalpha
Oct-08-17
10:48AMRoundtable: 1 Stock Retirees Should Consider Fool


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK